What is the risk of transcatheter aortic valve implantation (TAVI) in an 87‑year‑old patient with severe aortic stenosis, Montreal Cognitive Assessment (MoCA) score 18/30 (moderate cognitive impairment), moderate frailty, malnutrition, and a Timed Get‑Up‑and‑Go of 20 seconds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of TAVI in an 87-Year-Old with Cognitive Impairment, Frailty, and Malnutrition

This patient faces significantly elevated mortality risk after TAVI, with malnutrition and moderate frailty independently predicting 2-3 fold increased one-year mortality, though TAVI remains a reasonable option if severe symptomatic aortic stenosis is confirmed and life expectancy exceeds 1 year with potential for quality of life improvement. 1, 2, 3

Risk Stratification Based on Patient-Specific Factors

Malnutrition Impact

  • Malnutrition independently increases all-cause mortality by 2.32-fold (95% CI: 1.50-3.60) after TAVI, making this the single most concerning modifiable risk factor in your patient 1
  • Malnutrition affects 60-89% of TAVI patients depending on assessment tool, and is associated with older age, lower BMI, higher frailty, worse renal function, and anemia 1, 2
  • The Geriatric Nutritional Risk Index (GNRI) <98 identifies patients at nutrition-related risk with hazard ratio of 1.44 (95% CI: 1.01-2.04) for mortality 2
  • Acute Kidney Injury Network Stage 3 complications occur 6-fold more frequently in malnourished patients (3.6% vs 0.6%) 2

Frailty Impact

  • Moderate frailty independently predicts increased one-year mortality with OR 1.42 (95% CI: 1.02-1.96) after AVR procedures 3
  • Frailty and malnutrition share common endocrinological alterations including elevated cortisol and parathormone, with reduced IGF-1, testosterone, and DHEAS 3
  • The combination of frailty and malnutrition creates synergistic risk beyond either factor alone 3

Cognitive Impairment Considerations

  • MoCA score of 18/30 indicates moderate cognitive impairment, which raises critical questions about informed consent capacity, post-procedural rehabilitation potential, and quality of life improvement 4
  • Guidelines emphasize that patients with comorbidities preventing quality of life improvement should be excluded from TAVI 5
  • Life expectancy <1 year or moderate-to-severe dementia are relative contraindications to TAVI 4, 5

Functional Status Assessment

  • Timed Get-Up-and-Go >20 seconds indicates significant functional impairment and poor rehabilitation potential, which compounds the risk profile 4
  • This prolonged time suggests impaired mobility that may limit post-procedural recovery and independence 3

Procedural Risk Assessment Algorithm

Step 1: Confirm Severe Aortic Stenosis

  • TAVI should only be performed for confirmed severe AS (valve area ≤1.0 cm², mean gradient ≥40 mmHg, or peak velocity ≥4.0 m/sec) 6, 7
  • Use echocardiography with combined measurements of valve area and flow-dependent indices 7
  • If low-flow, low-gradient suspected, perform dobutamine stress echocardiography to exclude pseudo-severe stenosis 7

Step 2: Evaluate Life Expectancy and Quality of Life Potential

  • Patients with life expectancy <1 year should not receive TAVI 4, 5
  • At 87 years with moderate frailty, malnutrition, cognitive impairment (MoCA 18/30), and poor functional status (Get-Up-and-Go >20 sec), carefully assess whether intervention will meaningfully improve quality of life 4
  • The decision requires multidisciplinary Heart Team evaluation including cardiologists, cardiac surgeons, geriatricians, and anesthesiologists 4

Step 3: Calculate Surgical Risk Scores

  • Use EuroSCORE II or STS-PROM to quantify surgical risk, though these scores have reduced predictive ability in very high-risk elderly patients 4
  • At age 87 with multiple comorbidities, this patient likely has prohibitive surgical risk, making TAVI the only potential intervention option 4

Step 4: Assess Anatomical Feasibility

  • Perform coronary angiography to exclude severe proximal coronary stenoses not amenable to PCI 7
  • Measure aortic annulus (acceptable range 18-25 mm for balloon-expandable, 20-27 mm for self-expandable devices) 7
  • Evaluate peripheral artery size, tortuosity, and calcification via angiography or CT 7
  • Exclude bicuspid valve, asymmetric heavy calcification, and LV thrombus 7

Expected Outcomes in This High-Risk Patient

Mortality Risk

  • Baseline 30-day mortality for standard TAVI is 5-18% 5
  • With malnutrition, expect 2-3 fold increased mortality risk 1, 2
  • One-year mortality in malnourished, frail patients approaches 30-40% based on combined risk factors 1, 2, 3

Complication Risk

  • Procedural success rate remains 90-93.8% even in high-risk patients 5
  • Vascular complications occur in 10-15% of cases 5
  • Stroke risk is 3-9% 5
  • AKI Stage 3 risk is significantly elevated (3.6%) in malnourished patients 2
  • Paravalvular regurgitation occurs in 50% of cases, though severe regurgitation should be <5% 7

Functional Recovery

  • Postoperative complications (major and minor) occur in approximately 50% of elderly patients with poor nutritional status 8
  • 30-day functional capacity is reduced in urgent/high-risk TAVI patients, though survivors show improvement 9
  • With Get-Up-and-Go >20 seconds and moderate frailty, rehabilitation potential is limited 3

Critical Decision Points

When TAVI May Be Reasonable

  • If severe symptomatic AS is confirmed, symptoms are clearly attributable to valve disease, and estimated life expectancy exceeds 1 year with potential for meaningful quality of life improvement 4
  • If patient and family understand the 30-40% one-year mortality risk and accept this in context of symptom relief 1, 2
  • If anatomical assessment confirms feasibility without contraindications 7

When TAVI Should Be Avoided

  • If cognitive impairment (MoCA 18/30) prevents meaningful informed consent or suggests dementia severity that precludes quality of life benefit 4, 5
  • If life expectancy is estimated <1 year based on combined comorbidities 4, 5
  • If malnutrition and frailty are so severe that rehabilitation is futile 3, 8
  • If unintentional weight loss >2.8% in preceding 6 months, which predicts first-year mortality 8

Common Pitfalls to Avoid

  • Do not proceed with TAVI based solely on age and surgical risk scores without comprehensive geriatric assessment including cognitive function, frailty, nutrition, and rehabilitation potential 4
  • Do not underestimate the mortality impact of malnutrition—it rivals or exceeds traditional cardiac risk factors 1, 2
  • Do not assume all 87-year-olds are the same—functional status and cognitive function vary dramatically and determine outcomes 3, 8
  • Consider pre-procedural nutritional optimization if time permits, though evidence for this strategy improving TAVI outcomes is limited 1, 2
  • Ensure intensive care monitoring for at least 24 hours post-procedure given elevated complication risk 5

References

Research

Frailty, malnutrition, and the endocrine system impact outcome in patients undergoing aortic valve replacement.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

TAVI with ECMO Support: Not Recommended as Routine Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Aortic Stenosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

TAVI Procedure Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.